Dynavax Technologies | Renteudgifter På Gæld



Interest Expense On Debt Lave om Dato
AbbVie USD 610M 19M 2024-12
Adma Biologics USD 3.5M 284K 2024-09
Amgen USD 747M 29M 2024-12
AstraZeneca 429M 28M 2024-12
Biogen USD 60M 200K 2024-12
BioMarin Pharmaceutical USD 2.58M 391K 2024-12
Bristol-Myers Squibb USD 496M 9M 2024-12
Dynavax Technologies USD 1.7M 5K 2024-12
Gilead Sciences USD 248M 10M 2024-12
Glaxosmithkline 178.05M 24.73M 2024-12
Merck USD 328M 2M 2024-12
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 275M 11M 2024-12
Pfizer USD 739M 45M 2024-12
Regeneron Pharmaceuticals USD 10.5M 3.3M 2024-12
Roche Holding CHF 311.5M 1000K 2024-12
Sarepta Therapeutics USD 4.92M 86K 2024-09
TG Therapeutics USD 10.83M 6.86M 2024-09
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12



Dynavax Technologies Renteudgifter På Gæld - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.